Metabolic reprogramming and drug resistance in hepatocellular carcinoma: The emerging role of SREBP2-driven cholesterol metabolism
Year: 2026
Type: review
Source: Drug Discovery Today
Institutions: The University of Texas Rio Grande Valley, Clemson University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7204451618
